Hansoh $1bn IPO wins early demand
Hansoh Pharmaceutical Group kicked off the roadshow for its Hong Kong listing this week, with up to HK$7.9bn ($1bn) of proceeds in its sights. The deal got off to a strong start with the help of a cornerstone group that included Singapore’s sovereign wealth fund, as well as an early turnout from international institutions. Jonathan Breen reports.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: